Jyothy Labs reported a net profit of ₹76.3 crore in March 31, 2025 Q4, which was lower by 2.4% compared to ₹78.2 crore in the corresponding quarter of the previous year. The quarter ended March 2025 revenue of the company was ₹667 crore, up 1.1% from year ago ₹660 crore in Q4 FY24.
Operating performance was marginally improved with EBITDA increasing by 3.1% to ₹112 crore in Q4 FY25 from ₹108.5 crore in the same quarter last year. EBITDA operating margin during the quarter was better at 16.8% compared to 16.4% in the same quarter of the previous fiscal.
Improved operating margin is a reflection of improved cost efficiency and consistent expense management even when there is no growth in revenue.
Board of Company has also suggested payment of final dividend of ₹3.50 per equity share for 2024–25, pending approval of the shareholders in the upcoming Annual General Meeting. Date of AGM and record date as regards to entitlement to dividend will be communicated later by the company.
Jyothy Labs has been delivering good numbers in an increasingly improving FMCG scenario with a glimpse of operating excellence in the near future as bottom-line growth remains under marginal pressure.
Related Tags
Invest wise with Expert advice
IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000
IIFL Capital Services Support WhatsApp Number
+91 9892691696
IIFL Capital Services Limited - Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248
ARN NO : 47791 (AMFI Registered Mutual Fund Distributor)
This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.